A BILL 
To direct the Secretary of Veterans Affairs to study and 
report on the prevalence of cholangiocarcinoma in vet-
erans who served in the Vietnam theater of operations 
during the Vietnam era, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Vietnam Veterans 
4
Liver Fluke Cancer Study Act’’. 
5
00:54 Mar 21, 2021
H1273
2 
•HR 1273 IH
SEC. 
2. 
STUDY 
ON 
THE 
PREVALENCE 
OF 
1
CHOLANGIOCARCINOMA IN VETERANS WHO 
2
SERVED IN THE VIETNAM THEATER OF OPER-
3
ATIONS DURING THE VIETNAM ERA. 
4
(a) EPIDEMIOLOGICAL STUDY.—Not later than 120 
5
days after the date of enactment of this Act, the Secretary 
6
of Veterans Affairs, in consultation with the Director of 
7
the Centers for Disease Control and Prevention of the De-
8
partment of Health and Human Services, shall commence 
9
an 
epidemiological 
study 
on 
the 
prevalence 
of 
10
cholangiocarcinoma in covered veterans of the Vietnam 
11
era, using data from the Veterans Affairs Central Cancer 
12
Registry and the National Program of Cancer Registries. 
13
The study shall— 
14
(1) 
identify 
the 
rate 
of 
incidence 
of 
15
cholangiocarcinoma in covered veterans of the Viet-
16
nam era and in residents of the United States, from 
17
the beginning of the Vietnam era to the date of en-
18
actment of this Act; and 
19
(2) for each of the groups specified in para-
20
graph (1), identify the percentage of individuals with 
21
cholangiocarcinoma by various demographic charac-
22
teristics, including by age, gender, race, ethnicity, 
23
and the geographic location of the patient at the 
24
time of diagnosis. 
25
00:54 Mar 21, 2021
H1273
3 
•HR 1273 IH
(b) REPORT TO CONGRESS.—Not later than one year 
1
after the completion of the study under subsection (a), the 
2
Secretary shall submit to Congress a report containing— 
3
(1) the results of the study under subsection 
4
(a); and 
5
(2) recommendations for administrative or leg-
6
islative actions required to address issues identified 
7
in the study under subsection (a). 
8
(c) 
CONTINUED
TRACKING
OF 
9
CHOLANGIOCARCINOMA IN COVERED VETERANS OF THE 
10
VIETNAM ERA.—The Secretary shall track the prevalence 
11
of cholangiocarcinoma in covered veterans of the Vietnam 
12
era using the Veterans Affairs Central Cancer Registry, 
13
and provide such information to Congress as required 
14
under subsection (d). 
15
(d) FOLLOW-UP REPORTS.—The Secretary shall pe-
16
riodically submit to the Congress an updated report under 
17
subsection (b), as determined by the Secretary. 
18
(e) DEFINITIONS.—In this section: 
19
(1) The term ‘‘Secretary’’ means the Secretary 
20
of Veterans Affairs. 
21
(2) The term ‘‘Vietnam era’’ has the meaning 
22
given such term in section 101 of title 38, United 
23
States Code. 
24
00:54 Mar 21, 2021
H1273
4 
•HR 1273 IH
(3) The term ‘‘covered veterans of the Vietnam 
1
era’’ means veterans who served in the Vietnam the-
2
ater of operations during the Vietnam era. 
3
Æ 
00:54 Mar 21, 2021
H1273
